CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN
The article presents the review of clinical studies that determined the role of apixaban in the early treatment and long-term secondary prophylaxis of deep vein thrombosis and lower limbs and and/or pulmonary arteries embolism. It also defines a patient population for whom apixaban administration is...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«REMEDIUM GROUP» Ltd.
2015-12-01
|
| Series: | Атеротромбоз |
| Subjects: | |
| Online Access: | https://www.aterotromboz.ru/jour/article/view/45 |
| _version_ | 1797883976263663616 |
|---|---|
| author | I. S. Yavelov |
| author_facet | I. S. Yavelov |
| author_sort | I. S. Yavelov |
| collection | DOAJ |
| description | The article presents the review of clinical studies that determined the role of apixaban in the early treatment and long-term secondary prophylaxis of deep vein thrombosis and lower limbs and and/or pulmonary arteries embolism. It also defines a patient population for whom apixaban administration is justified on the basis of pilot studies and the clinical data accumulated to date at various clinics. |
| first_indexed | 2024-04-10T03:59:10Z |
| format | Article |
| id | doaj.art-2b0b9a0766fb4703bca88c627d512f6a |
| institution | Directory Open Access Journal |
| issn | 2307-1109 2658-5952 |
| language | Russian |
| last_indexed | 2024-04-10T03:59:10Z |
| publishDate | 2015-12-01 |
| publisher | «REMEDIUM GROUP» Ltd. |
| record_format | Article |
| series | Атеротромбоз |
| spelling | doaj.art-2b0b9a0766fb4703bca88c627d512f6a2023-03-13T07:10:41Zrus«REMEDIUM GROUP» Ltd.Атеротромбоз2307-11092658-59522015-12-0102323810.21518/2307-1109-2015-2-32-3841CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABANI. S. Yavelov0ведущий научный сотрудник ФГБУН «НИИ физико-химической медицины» ФМБА России, г. МоскваThe article presents the review of clinical studies that determined the role of apixaban in the early treatment and long-term secondary prophylaxis of deep vein thrombosis and lower limbs and and/or pulmonary arteries embolism. It also defines a patient population for whom apixaban administration is justified on the basis of pilot studies and the clinical data accumulated to date at various clinics.https://www.aterotromboz.ru/jour/article/view/45тромбоз глубоких вентромбоэмболия легочных артерийпероральные антикоагулянтыапиксабан |
| spellingShingle | I. S. Yavelov CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN Атеротромбоз тромбоз глубоких вен тромбоэмболия легочных артерий пероральные антикоагулянты апиксабан |
| title | CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN |
| title_full | CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN |
| title_fullStr | CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN |
| title_full_unstemmed | CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN |
| title_short | CURRENT TREATMENT OF VENOUS THROMBOEMBOLIC COMPLICATIONS WITH ANTICOAGULANTS: APIXABAN |
| title_sort | current treatment of venous thromboembolic complications with anticoagulants apixaban |
| topic | тромбоз глубоких вен тромбоэмболия легочных артерий пероральные антикоагулянты апиксабан |
| url | https://www.aterotromboz.ru/jour/article/view/45 |
| work_keys_str_mv | AT isyavelov currenttreatmentofvenousthromboemboliccomplicationswithanticoagulantsapixaban |